$0.76
▼ $-0.01
(-1.68%)
Vol 5K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$176.9M
ROE
-11.6%
Margin
-10.1%
D/E
41.98
Beta
0.79
52W
$354–$670
Wall Street Consensus
7 analysts · Jun 20252
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2023 | $0.08 | $0.11 | +$0.02 |
| Mar 2023 | $0.04 | $0.01 | $-0.04 |
| Dec 2022 | $0.18 | $0.19 | +$0.00 |
| Sep 2022 | $0.26 | $0.16 | $-0.10 |
Fundamentals Trend
| Metric | 2024-12-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -11.6% | -11.6% | -11.6% | -11.6% | -11.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -28.4% | -10.1% | -10.1% | -10.1% | -10.1% | -10.1% |
| Gross Margin | 14.9% | 31.2% | 31.2% | 31.2% | 31.2% | 31.2% |
| D/E Ratio | — | 41.98 | 41.98 | 41.98 | 41.98 | 41.98 |
| Current Ratio | — | 1.85 | 1.85 | 1.85 | 1.85 | 1.85 |
Key Ratios
ROA (TTM)
-6.8%
P/S (TTM)
0.31
P/B
1.1
EPS (TTM)
$-1.26
CF/Share
$0.52
Rev Growth 3Y
+2.8%
52W High
$670.00
52W Low
$354.00
$354.00
52-Week Range
$670.00
Financial Health
Net Debt
$133.1M
Cash
$78.3M
Total Debt
$211.4M
As of Dec 31, 2024
How does INCR compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
INCR valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0.3
▼
94%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
1.1
▼
47%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
INCR profitability vs Pharmaceuticals peers
ROE
-11.6%
▲
79%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-10.1%
▲
79%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
31.3%
▼
54%
below
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-6.8%
▲
82%
above
peers
(-37.4%)
vs Peers
vs Industry
Top tier
INCR financial health vs Pharmaceuticals peers
D/E ratio
42.0
▲
2626%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
1.9
▼
45%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
0.8
▼
16%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
INCR fundamentals radar
INCR
Peer median
Industry
INCR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
INCR vs peers: key metrics
Latest News
The Metals Company Inc. Just Got Incredible News from the NOAA. Here's …
Nasdaq · Apr 05
Stock Market Volatility is Increasing: 1 Spectacular Stock You Can Buy at …
Nasdaq · Apr 05
5 Incredible AI Stocks to Buy in April
Nasdaq · Apr 04
Metals One rises 7% as it moves to take option to increase …
Yahoo Finance · Apr 03
Iran war may increase mortgage payments for extra 1.3m UK households, says …
The Guardian · Apr 01